PCNA-targeting peptides were shown to inhibit the growth or to induce apoptosis in neuroblastoma, hormone-insensitive prostate cancer, triple-negative breast cancer, bladder cancer, and multiple myeloma (31, 32, 38, 40, 41). The gene discussed is PCNA; the disease is AL amyloidosis.